• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home Career Development

Australian couple-based genetic screening program feasible and accepted

byMichaela Dowling, MDandKiera Liblik
December 11, 2024
in Career Development, ENT, Obstetrics, Pharma, Public Health
Reading Time: 3 mins read
Maternal cell-free DNA sequencing superior to standard aneuploidy screening [CARE Study]
Share on FacebookShare on TwitterShare on LinkedIn

1. In this prospective cohort study, genetic screening among Australian reproductive couples was widely accepted and associated with low decisional regret.

2. Three out of four couples identified as having an increased risk of having a child with a genetic condition opted for reproductive interventions.

Evidence Rating Level: 2 (Good)

Study Rundown: Reproductive genetic screening offers individuals insight into their risk of having a child affected by genetic conditions, particularly X-linked or autosomal recessive ones. However, financial barriers often limit access, as commercialization drives up costs in many countries. Additionally, concerns surrounding accessibility, feasibility, and ethics have led to inconsistent implementation of government-funded programs worldwide. This Australian study evaluated the feasibility and acceptability of a nationwide couple-based genetic screening program encompassing 1,281 genes. Most couples were found to have a low risk of having a child with a screened genetic condition. Of the couples identified as high risk, fewer than a quarter were considered high risk before the screening. Notably, the majority of high-risk couples adjusted their reproductive plans based on the results. Decisional regret was low across all participants, regardless of their outcomes. In addition, very few participants did not support the implementation of a nationwide genetic screening program at the three-month time point. However, this screening program focused on severe childhood-onset conditions or those where early intervention could improve prognosis. It did not include all genetic conditions. As well, the study underrepresented Indigenous communities, individuals with lower educational attainment, and those from lower socioeconomic backgrounds. Despite these limitations, the findings support the feasibility and acceptability of a nationwide genetic carrier screening program in Australia.

Click here to read the study in the NEJM (New England Journal of Medicine)

Relevant Reading: Genetic Carrier Screening — Call for a Global Mission

RELATED REPORTS

Chronic exposure to particulate matter is associated with increased cardiovascular risk

Mortality in the post-housing period is high among homeless people in Ottawa, Canada

In-Depth [prospective cohort]: This study assessed the acceptability and feasibility of implementing a nationwide genetic carrier screening program for reproductive couples in Australia. Eligible participants included opposite-chromosomal-sex couples aged 18 or older who planned to conceive or were within 10 weeks of gestation. Couples with a known family history of genetic conditions could participate, and no explicit exclusion criteria were applied. Approximately 19,000 couples were invited to participate, and 9,107 (45.9%) eventually underwent genetic screening. Among the couples screened, 8,756 (96.1%) had a low risk of having a child with a genetic condition. Of the 355 couples identified as high-risk, 180 (50.7%) were already known to be at risk, while 175 (49.3%) were newly identified. Most newly identified couples (74.3%) were at risk for autosomal recessive conditions, while the rest (25.7%) were at risk for X-linked genetic conditions. Of these couples, 76.6% decided to alter their reproductive plans based on the results. A three-month follow-up survey was completed by 30.9% of participants, the majority (69.7%) identifying as female. There were no significant changes in participants’ health-related quality of life (measured using AQoL-4D) between enrollment and the follow-up. However, state anxiety, as measured by a six-item version of the state-trait anxiety inventory, was found to have increased from baseline in the groups identified to be at high risk. Decisional regret, measured on a Decision Regret Scale (0–100), was low overall. Indeed, over half (54.4%) of all participants indicated no regret in completing the screening program. The highest level of regret, with a median score of 15.0 (IQR, 10.0–25.0), was observed among newly identified high-risk couples. Nevertheless, 4323 of the 4376 (98.8%) of respondents supported making genetic carrier screening accessible to all couples. These findings underscore the program’s acceptability, usability, and feasibility, suggesting the potential for broader implementation of genetic screening in reproductive care.

Image: PD

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: genetic screeninggeneticsobstetricspreventative medicinepublic health
Previous Post

#VisualAbstract: Twice-Yearly Lenacapavir is Effective for Human Immunodeficiency Virus Prevention in Men and Gender-Diverse Persons

Next Post

Reduced pneumococcal vaccine schedules non-inferior to WHO recommendations

RelatedReports

A senior woman looks thoughtfully at a balance scale with a stethoscope and a heart illustration, symbolizing the assessment of cardiovascular risk and treatment decisions.
Cardiology

Chronic exposure to particulate matter is associated with increased cardiovascular risk

September 10, 2026
Homelessness and health collage: a park bench with a bedroll and backpack, a path to a building with one lit window
Public Health

Mortality in the post-housing period is high among homeless people in Ottawa, Canada

August 31, 2026
Reproductive health collage: a halved pomegranate, a sprig of baby's breath and a paper door ajar with light coming through
Obstetrics

A landmark court ruling was associated with increased travel across state borders for abortion care

August 28, 2026
Digital health collage: an open laptop with a blank glowing screen under a network of dots, a stethoscope and a padlock
Chronic Disease

Many patients using patient portals may not fully understand results of laboratory testing

August 26, 2026
Next Post

Reduced pneumococcal vaccine schedules non-inferior to WHO recommendations

Early oral anticoagulation is non-inferior to delayed treatment in patients with ischemic stroke and atrial fibrillation

Increased risk of subsequent melanoma after first melanoma diagnosis

Neoadjuvant ipilimumab plus nivolumab improves event-free survival in stage III melanoma

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Spousal traumatic brain injury is associated with increased mortality in the uninjured partner
  • Use of β3 adrenergic agonists and anticholinergics for overactive bladder are associated with similar dementia risk
  • Obesity associated with higher early-onset cancer risk among young Korean adults
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.